The global digital mammography market size was USD 1.35 Billion in 2022 and is likely to reach USD 3 Billion by 2031, expanding at a CAGR of 10.25% during the forecast period, 2023–2031. The market growth is attributed to the widespread deployment of Artificial Intelligence (AI) and Machine Learning (ML) technology in medical devices developed for healthcare diagnostics and treatment applications.
Rising implementation of advanced medical devices and machines in healthcare settings is majorly supporting the demand for digital mammography solutions. Next-generation technologies such as AI and ML provide a second opinion on the diagnosis and are a safety net that helps boost the radiologist's confidence. This factor is expected to boost the market.
AI aids the mammography method by substantially reducing the workload of double reading by radiologists. It expands cancer detection without increasing false positive findings. Companies in the market are formulating various strategies including partnerships and collaborations to expand the use of technology in healthcare diagnostics such as mammography.
-
On August 6, 2020, RadNet, Inc. and Hologic, Inc. announced a definitive collaboration to advance the use of AI tools in breast health. This collaboration enables joint market opportunities and more efforts to build clinician self-confidence and integrate new AI technologies.
The market report finds that the COVID-19 pandemic hampered the digital mammography market, due to the substantial reductions in breast cancer screening, cancer administration screening, and procedures all over the world. Several healthcare facilities postponed all breast screening exams, owing to infection concerns.
The decline in hospitals or medical sectors caused by COVID-19 presented radiotherapies providing facilities with additional challenges, which, in turn, hindered the digital mammography market.
-
According to the Centers for Disease Control and Prevention (CDC), in 2020, the number of cancer tests taken by women through the CDC’s National Breast and Cervical Cancer Early Detection Program (Early Detection Program), was reduced by around 87% for breast cancer and 84% were declined for cervical cancer as compared with the previous year's averages.
Digital Mammography Market Dynamics
Major Drivers
Increasing number of breast cancers among women is expected to fuel the digital mammography market. Digital mammography is a highly accurate tool for breast cancer detection. It offers good-quality imaging with less radiation dose. The digital technique efficiently detects breast carcinoma in its early stages, which results in a good prognosis and improves patient survival.
-
According to the World Health Organization (WHO), around 2.3 million women were diagnosed with breast cancer and it caused 685,000 deaths worldwide in 2021. The report further states that breast cancer occurrence in men is around 0.5 to 1%.
Existing Restraints
High costs and a lack of awareness about mammography devices are expected to hamper the digital mammography market. Access to digital mammography services is limited in some areas, predominantly low-income areas or rural communities. Further, a lack of awareness about the importance of regular screening with a mammogram and limited healthcare infrastructure can hinder the adoption of digital mammography.
These systems tend to be more expensive than traditional film-based systems, which can pose a financial challenge to health facilities, especially in developing countries such as China, and India with limited resources. The initial investment cost can be significant along with maintenance costs, upgrading, and training, which can further affect the market.
Emerging Opportunities
Rising research & development activities for introducing new products are expected to create lucrative opportunities for the market players. Several companies are focusing to develop innovative products for digital mammography, which can easily and efficiently detect breast cancer tissue. Such measures are expected to minimize error occurrence during diagnostics and provide the most accurate results, which can enable better and focused treatment for cure.
-
On October 19, 2022, the American College of Radiology (ACR) partnered with GE Healthcare and the Breast Cancer Research Foundation, to launch a contrast-enhanced mammography imaging screening trial (CMIST). This partnership is aimed to determine whether contrast-enhanced mammography improves breast cancer detection and lessens false positive exams in women with dense breasts.
Scope of Digital Mammography Market Report
The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Digital Mammography Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product (3D Full Field Digital Mammography and 2D Full Field Digital Mammography), Technology (Display Units, Digital Mammography Systems, Visualization Software, and Central Processing Units), and End-user (Hospitals, Diagnostic Centers, Research Institutes, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Toshiba Corporation; Siemens Healthcare GmbH; Shenzhen Landwind Industry Co.; Shenzhen Angell Technology Co., Ltd.; PLANMED OY; Metaltronica S.p.A.; Koninklijke Philips N.V.; Kangda Intercontinental Medical Equipment Co, Ltd; Hologic, Inc.; GE HealthCare; UNC Health Pardee; FUJIFILM Holdings Corporation; Radiological Society of North America; and DMS Health.
|
Digital Mammography Market Segment Insights
Product Segment Analysis
Based on product, the digital mammography market is divided into 3D full field digital mammography and 2D full field digital mammography. The 2D full field digital mammography segment is expected to expand at a significant pace during the projection period, as it is a more accurate depiction of breast tissue.
2D mammography, also called conventional digital mammography, is typically performed by taking two pictures of each breast, one from the above and another from the side. 2D mammography show areas of overlapping breast tissue on the images. The segment is further supported by the price difference between 2D and 3D mammography, as the former is more cost-effective than the latter.
The 3D full field digital mammography segment is anticipated to hold a key share of the market in the coming years, as it detects small cancers and masses hidden in dense breast tissue. 3D mammography is also called digital breast tomosynthesis which is typically taken with multiple pictures of the breast from different angles.
3D mammography improves the ability of mammography to detect early breast cancers. The 3D images help minimize the overlapping of breast tissue and make it easier for radiologists to detect breast tissue on mammography, as they can look at the breast from different angles.
-
In May 2023, TGH Imaging, a subspecialty for diagnostic imaging extended its Genius 3D mammography services across 18 centers in four countries. This genius 3D mammography can considerably improve the observation of breast cancers and decreases the necessity for additional testing.
Technology Segment Analysis
On the basis of technology, the global market is segregated into display units, digital mammography systems, visualization software, and central processing units. The visualization software segment is projected to register a considerable CAGR during the forecast period, as it helps doctors to detect tumors with greater accuracy than by using current X-ray mammography.
The visualization tools are specifically designed for medical imaging, including mammographic imaging, and are commonly used as part of medical image visualization and manipulation stations. The visualization tools are improving with advances in technology. Companies in the market are utilizing tools such as AI, to gain better visualization of cancer-affected cells. All of these factors are leading to the growth of the segment.
End-user Segment Analysis
Based on end-user, the digital mammography market is segmented into hospitals, diagnostic centers, research institutes, and others. The hospitals segment is expected to register a robust growth rate during the forecast period, due to the availability of advanced facilities offered by the healthcare sector for cancer detection.
Hospitals are well-equipped with advanced 3D and 2D mammography technologies. In addition, government hospitals around the world are also upgrading facilities with digital technology to offer cost-effective diagnostic services, which, in turn, is likely to boost the demand for digital mammography systems.
The diagnostic centers segment is projected to hold a significant market share in the coming years, due to the increasing availability of inclusive breast imaging services at cost-effective prices. Surgeons, breast radiologists, and reconstructive surgeons work efficiently with patients in breast imaging clinics to create and implement customized treatment plans.
Regional Analysis
In terms of region, the global digital mammography market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to the consistent improvements in breast imaging modalities and the increasing prevalence of breast cancer.
The rise of government support and investment in the development of healthcare infrastructure is also expected to boost the market in the region.
-
According to the American Cancer Society, in the US, it is estimated that in 2023, around 297,790 new cases will be diagnosed with invasive breast cancer in women. Around 43,700 women are likely to die from breast cancer mentions the report.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, owing to the increasing awareness about the usage of mammography technologies and the rising prevalence of breast cancer. Several government initiatives for free cancer treatment programs are increasing in emerging countries such as India, which is likely to boost the market in the region.
- According to the National Cancer Registry Program Report 2020, it was estimated that more than 2 lakh women have been diagnosed with breast cancer in India and more than 76,00 deaths were reported. In 2025. the number of breast cancer diagnoses is expected to increase by more than 2.3 lakh cases denotes the report.
Segments
The global digital mammography market has been segmented on the basis of
Product
- 3D Full Field Digital Mammography
- 2D Full Field Digital Mammography
Technology
- Display Units
- Digital Mammography Systems
- Visualization Software
- Central Processing Units
End-user
- Hospitals
- Diagnostic Centers
- Research Institutes
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Toshiba Corporation
- Siemens Healthcare GmbH
- Shenzhen Landwind Industry Co.
- Shenzhen Angell Technology Co., Ltd.
- PLANMED OY
- Metaltronica S.p.A.
- Koninklijke Philips N.V.
- Kangda Intercontinental Medical Equipment Co, Ltd
- Hologic, Inc.
- GE HealthCare
- UNC Health Pardee
- FUJIFILM Holdings Corporation
- Radiological Society of North America
- DMS Health.
Competitive Landscape
Key players competing in the global digital mammography market are Toshiba Corporation; Siemens Healthcare GmbH; Shenzhen Landwind Industry Co.; Shenzhen Angell Technology Co., Ltd.; PLANMED OY; Metaltronica S.p.A.; Koninklijke Philips N.V.; Kangda Intercontinental Medical Equipment Co, Ltd; Hologic, Inc.; GE HealthCare; UNC Health; FUJIFILM Holdings Corporation; Radiological Society of North America; and DMS Health.
These prominent market players are adopting various strategies to develop a presence in the digital mammography space. These strategies include product launches, acquisitions, collaboration, partnerships, mergers, and production expansion to expand their consumer base globally.
-
In December 2022, the Radiological Society of North America (RSNA) launched the Screening Mammography Breast Cancer Detection Artificial Intelligence (AI) challenge. This AI challenge was aimed to evaluate competitors in their capability to develop AI solutions to help in detecting breast cancer on screening mammography images.
-
In May 2023, UNC Health Pardee introduced the mobile mammography program “Mammo on the Go”, offering mammograms to local women in a more suitable format. This mammo on the go initiative provides digital 3D breast imaging, state-of-the-art, and initial detection services to women in Henderson, Buncombe, Transylvania, and Polk countries.
Request For Customization
Enquiry Before Buying
Speak With Analyst
